Home › Stocks › AVBP › All Fund Holders
AVBP — ARRIVENT BIOPHARMA INC · All Fund Holders
Funds holding (latest): 33 · Reported value held: $610.67M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Hillhouse Capital (HHLR Advisors) history | Q2 2026 | 3.93M | $136.50M | 16.41% | Hold |
| BlackRock Inc history | Q2 2026 | 3.25M | $112.92M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.78M | $96.54M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 1.87M | $37.61M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 972.63K | $33.80M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 872.01K | $30.29M | 0.02% | Add |
| Goldman Sachs Group history | Q2 2026 | 853.72K | $29.66M | 0.00% | Hold |
| Point72 Asset Management history | Q2 2026 | 566.80K | $19.69M | 0.02% | Reduce |
| Millennium Management history | Q2 2026 | 438.66K | $15.24M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 438.59K | $15.24M | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 395.45K | $13.74M | 0.02% | Reduce |
| Northern Trust Corp history | Q2 2026 | 332.75K | $11.56M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 294.22K | $10.22M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 238.34K | $8.28M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 189.91K | $6.60M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 174.87K | $6.07M | 0.00% | Add |
| Franklin Resources history | Q3 2025 | 256.42K | $4.73M | 0.00% | New |
| BNY Mellon history | Q2 2026 | 103.93K | $3.61M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 100.86K | $3.50M | 0.00% | Add |
| Farallon Capital Management history | Q1 2024 | 151.77K | $2.71M | 0.01% | New |
| JPMorgan Chase & Co history | Q2 2026 | 65.69K | $2.26M | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 57.80K | $2.01M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 41.27K | $1.43M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 39.18K | $1.36M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 36.67K | $1.27M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 32.97K | $1.15M | 0.00% | Add |
| Marshall Wace history | Q1 2026 | 35.16K | $811.26K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 21.52K | $747.50K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 15.48K | $537.81K | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 10.36K | $360.01K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 6.21K | $215.91K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 214 | $7.43K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 31.55K | $1.10K | 0.00% | Add |